Bortezomib induces heme oxygenase-1 expression in multiple myeloma
about
The Nrf2/HO-1 Axis in Cancer Cell Growth and ChemoresistanceOxidative stress responses and NRF2 in human leukaemiaNF-kappa B modulation is involved in celastrol induced human multiple myeloma cell apoptosisArsenic Trioxide Activate Transcription of Heme Oxygenase-1 by Promoting Nuclear Translocation of NFE2L2.Attenuation of dexamethasone-induced cell death in multiple myeloma is mediated by miR-125b expressionUnderstanding the role of NRF2-regulated miRNAs in human malignancies.DNA repair pathways in human multiple myeloma: role in oncogenesis and potential targets for treatment.Role of heme oxygenase-1 in postnatal differentiation of stem cells: a possible cross-talk with microRNAs.Overcoming bortezomib resistance in multiple myeloma.Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters.Heme oxygenase-1 silencing increases the sensitivity of human osteosarcoma MG63 cells to arsenic trioxide.HO-1 Induction in Cancer Progression: A Matter of Cell Adaptation.Heme oxygenase-1 nuclear translocation regulates bortezomibinduced cytotoxicity and mediates genomic instability in myeloma cells.Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma.Silencing heme oxygenase-1 increases the sensitivity of ABC-DLBCL cells to histone deacetylase inhibitor in vitro and in vivo.Old and Young Actors Playing Novel Roles in the Drama of Multiple Myeloma Bone Marrow Microenvironment Dependent Drug Resistance.Understanding life and death decisions in human leukaemias.
P2860
Q26772298-445FEAE5-5F07-429D-8826-F1B104769CA8Q26864239-053163CB-EC2C-4807-9548-D318399AC2B6Q28538133-15E84FC9-2308-44A6-8DC9-2674DF386E46Q35942156-E3DCB6C2-2067-45A9-A60F-56FFD297A940Q37079785-F25E7B4C-ACF1-4DD2-8C07-80233EF6DF05Q37207646-5761B999-13E5-4FAF-B574-973DEF485201Q37505517-60AD18F9-C968-4297-894A-7A283C037DD0Q37653706-266614CB-90A5-40E9-97C1-8B825AC9C99DQ38238610-76786E21-09D5-42E6-A77D-DB596062A932Q38869922-BD47B328-49CE-4897-9766-79D04BCF8554Q39010840-FCC7DF48-CF19-4A97-B72C-E57043FCB915Q39285687-065D1643-E4EF-4A26-A62E-A71ED98CAFFFQ39956732-A21A7C33-DD33-499B-AC17-6C7F434E2DDBQ41882913-8A09E187-E22A-45FA-9526-44B65B195F3EQ44315979-502C0E0A-2B7B-44AA-9FD8-3390F776F2C2Q55025408-3E5CADEF-4C96-4462-BAD8-A245D8CD6647Q55071953-5D005B90-A7FD-4474-BB67-BFAD66588F10
P2860
Bortezomib induces heme oxygenase-1 expression in multiple myeloma
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Bortezomib induces heme oxygenase-1 expression in multiple myeloma
@ast
Bortezomib induces heme oxygenase-1 expression in multiple myeloma
@en
type
label
Bortezomib induces heme oxygenase-1 expression in multiple myeloma
@ast
Bortezomib induces heme oxygenase-1 expression in multiple myeloma
@en
prefLabel
Bortezomib induces heme oxygenase-1 expression in multiple myeloma
@ast
Bortezomib induces heme oxygenase-1 expression in multiple myeloma
@en
P2093
P2860
P356
P1433
P1476
Bortezomib induces heme oxygenase-1 expression in multiple myeloma
@en
P2093
David J MacEwan
Kristian M Bowles
Lawrence N Barrera
Stuart A Rushworth
P2860
P304
P356
10.4161/CC.20343
P577
2012-06-15T00:00:00Z